
AstraZeneca hands over opioid addiction pill to Eolas; TandemAI, Perpetual Medicines merge
Plus, news about Pfizer and Astellas’ Xtandi, BeOne Medicines, Biocytogen and Rhythm:
Eolas Therapeutics takes opioid addiction pill from AstraZeneca: The biotech
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.